- Report
- August 2023
- 76 Pages
Turkey
From €3325EUR$3,500USD£2,860GBP
- Report
- April 2023
- 105 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- March 2023
- 100 Pages
Global
From €2613EUR$2,750USD£2,247GBP
- Report
- July 2022
- 100 Pages
Global
From €2613EUR$2,750USD£2,247GBP
- Report
- January 2022
- 200 Pages
Global
From €7125EUR$7,500USD£6,129GBP
- Report
- January 2022
- 200 Pages
Global
From €7125EUR$7,500USD£6,129GBP
- Report
- January 2022
- 60 Pages
Global
From €3753EUR$3,950USD£3,228GBP
- Report
- January 2022
- 60 Pages
Global
From €3753EUR$3,950USD£3,228GBP
- Clinical Trials
- January 2021
- 60 Pages
Global
From €1425EUR$1,500USD£1,226GBP
- Drug Pipelines
- January 2019
- 60 Pages
Global
From €1900EUR$2,000USD£1,634GBP
- Report
- August 2022
United States
From €1843EUR$1,940USD£1,585GBP
- Report
- August 2022
Global
From €751EUR$790USD£646GBP
- Report
- August 2021
Global
From €3791EUR$3,990USD£3,261GBP
- Report
- August 2021
Europe
From €3249EUR$3,420USD£2,795GBP
- Report
- February 2021
Global
From €2812EUR$2,960USD£2,419GBP
- Report
- August 2022
- 110 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- August 2022
- 116 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- December 2019
United States
From €7595EUR$7,995USD£6,534GBP
- Report
- October 2020
Europe
From €8546EUR$8,995USD£7,351GBP
- Report
- May 2022
- 334 Pages
Global
From €3026EUR$3,185USD£2,603GBP
€4323EUR$4,550USD£3,718GBP
The Fibroid market is a subset of the Women's Health market, focusing on the diagnosis and treatment of uterine fibroids. Fibroids are non-cancerous growths that can cause a variety of symptoms, including heavy menstrual bleeding, pelvic pain, and frequent urination. Treatment options range from medication to minimally invasive procedures to surgical removal.
The Fibroid market is a growing area of Women's Health, with a variety of companies offering products and services to diagnose and treat fibroids. Companies in the market include Hologic, Inc., Boston Scientific Corporation, Cook Medical, Inc., and Olympus Corporation. Show Less Read more